Development of Glycosaminoglycan-Interacting Small Molecules (GISMO) for the Treatment of Alzheimer's Disease

Grants and Contracts Details

StatusFinished
Effective start/end date2/15/14 → 1/13/17

Funding

  • Gismo Therapeutics Incorporated: $30,000.00